Sign in to view content

Reduction in the Frequency of Diabetic Macular Edema (DME) Therapies Post-0.2 ug/Day Fluocinolone Acetonide (FAc) Implant Treatment Results

Sam E. Mansour, MD, MSc,FACS, FRCS(C)

Video
Published 2018

Related

Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
Updates from the Field
2022
Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2018
Episode 164: Corticosteroids for Retinal Vascular Disease and Other Topics with Dr. Seenu Hariprasad
Jayanth Sridhar, MD
Member Podcasts
2018

Category: Diabetic Retinopathy

See more